- Home
- CEV vs BEAT Comparison
CEV vs BEAT Comparison
Compare CEV & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEV
- BEAT
- Stock Information
- Founded
- CEV 1999
- BEAT 2015
- Country
- CEV United States
- BEAT United States
- Employees
- CEV N/A
- BEAT N/A
- Industry
- CEV Finance/Investors Services
- BEAT Retail: Computer Software & Peripheral Equipment
- Sector
- CEV Finance
- BEAT Technology
- Exchange
- CEV Nasdaq
- BEAT Nasdaq
- Market Cap
- CEV 70.8M
- BEAT 58.0M
- IPO Year
- CEV N/A
- BEAT 2021
- Fundamental
- Price
- CEV $10.14
- BEAT $1.68
- Analyst Decision
- CEV
- BEAT Buy
- Analyst Count
- CEV 0
- BEAT 1
- Target Price
- CEV N/A
- BEAT $8.00
- AVG Volume (30 Days)
- CEV 19.6K
- BEAT 97.3K
- Earning Date
- CEV 01-01-0001
- BEAT 11-06-2025
- Dividend Yield
- CEV 4.23%
- BEAT N/A
- EPS Growth
- CEV N/A
- BEAT N/A
- EPS
- CEV 0.36
- BEAT N/A
- Revenue
- CEV N/A
- BEAT N/A
- Revenue This Year
- CEV N/A
- BEAT N/A
- Revenue Next Year
- CEV N/A
- BEAT $19.35
- P/E Ratio
- CEV $29.36
- BEAT N/A
- Revenue Growth
- CEV N/A
- BEAT N/A
- 52 Week Low
- CEV $8.83
- BEAT $0.91
- 52 Week High
- CEV $10.91
- BEAT $3.48
- Technical
- Relative Strength Index (RSI)
- CEV 73.08
- BEAT 54.69
- Support Level
- CEV $9.97
- BEAT $1.74
- Resistance Level
- CEV $10.17
- BEAT $1.89
- Average True Range (ATR)
- CEV 0.07
- BEAT 0.12
- MACD
- CEV -0.01
- BEAT -0.01
- Stochastic Oscillator
- CEV 83.38
- BEAT 18.87
About CEV Eaton Vance California Municipal Income Trust Shares of Beneficial Interest
Eaton Vance CA Muni Income Trust is a non-diversified closed-end investment company. The company's investment objective is to provide current income exempt from regular federal income tax and California state personal income taxes. It invests in municipal obligations, issued by the State of California or its political subdivisions, agencies, authorities and instrumentalities and also has some exposure to corporate bonds.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.